183 related articles for article (PubMed ID: 28771789)
1. Secukinumab-induced interstitial pneumonia in a patient with psoriasis vulgaris.
Kajihara I; Yamada-Kanazawa S; Maeda-Otsuka S; Jinnin M; Akaike K; Ihn H
J Dermatol; 2017 Dec; 44(12):e322-e323. PubMed ID: 28771789
[No Abstract] [Full Text] [Related]
2. Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris.
Hayashi M; Igarashi A; Okamura K; Suzuki T
Br J Dermatol; 2019 Mar; 180(3):684-685. PubMed ID: 30430554
[No Abstract] [Full Text] [Related]
3. Improvement of the initial stage of interstitial lung disease during psoriasis treatment with secukinumab.
Miyachi H; Nakamura Y; Nakamura Y; Matsue H
J Dermatol; 2017 Dec; 44(12):e328-e329. PubMed ID: 28891081
[No Abstract] [Full Text] [Related]
4. Respiratory failure due to infliximab induced interstitial lung disease.
Kakavas S; Balis E; Lazarou V; Kouvela M; Tatsis G
Heart Lung; 2013; 42(6):480-2. PubMed ID: 23969008
[TBL] [Abstract][Full Text] [Related]
5. [Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].
Sorger C; Simon JC; Treudler R
Hautarzt; 2020 Apr; 71(4):309-312. PubMed ID: 31792580
[TBL] [Abstract][Full Text] [Related]
6. [Interstitial pneumonia after infliximab therapy for psoriasis].
Leger S; Etienne M; Duval-Modeste AB; Roussel A; Caron F; Thiberville L
Ann Dermatol Venereol; 2011; 138(6-7):499-503. PubMed ID: 21700071
[TBL] [Abstract][Full Text] [Related]
7. A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus.
Kishi J; Nanki T; Watanabe K; Takamura A; Miyasaka N
Rheumatology (Oxford); 2009 Apr; 48(4):447-8. PubMed ID: 19202159
[No Abstract] [Full Text] [Related]
8. Serum KL-6 levels in Japanese patients with psoriasis treated with secukinumab.
Kurita M; Kikuchi S; Umezawa Y; Asahina A; Nakagawa H; Yanaba K
J Dermatol; 2019 Apr; 46(4):e115-e116. PubMed ID: 30204267
[No Abstract] [Full Text] [Related]
9. Psoriasis-associated interstitial pneumonia.
Hara H; Kuwano K; Kawamoto H; Nakagawa H
Eur J Dermatol; 2018 Jun; 28(3):395-396. PubMed ID: 29521628
[No Abstract] [Full Text] [Related]
10. Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment.
Yasuda M; Morimoto N; Yonemoto Y; Sunaga N; Ishikawa O
Eur J Dermatol; 2019 Feb; 29(1):81-82. PubMed ID: 30530442
[No Abstract] [Full Text] [Related]
11. Case records of the Massachusetts General Hospital. Case 33-2008. A 63-year-old woman with dyspnea on exertion.
Wiener CM; Muse VV; Mark EJ
N Engl J Med; 2008 Oct; 359(17):1823-32. PubMed ID: 18946068
[No Abstract] [Full Text] [Related]
12. Ixekizumab-induced Interstitial Lung Disease.
Ahmed A; Khanna P; Al Omari O; Jani C; Patel D; Singh H; Schiffman R
Am J Ther; 2024 May-Jun 01; 31(3):e315-e318. PubMed ID: 37418343
[No Abstract] [Full Text] [Related]
13. Rituximab-induced interstitial pneumonia due to CD8-positive T cell infiltration.
Sato K; Nagai T; Izumi T; Ohmine K; Ozaki K; Muroi K; Ozawa K
Acta Haematol; 2012; 128(2):107-9. PubMed ID: 22760000
[No Abstract] [Full Text] [Related]
14. Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement.
Komiya K; Ishii H; Fujita N; Oka H; Iwata A; Sonoda H; Kadota J
Intern Med; 2011; 50(7):749-51. PubMed ID: 21467710
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer.
Kato T; Masuda N; Nakanishi Y; Takahashi M; Hida T; Sakai H; Atagi S; Fujita S; Tanaka H; Takeda K; Satouchi M; Namba Y; Tamura T
Lung Cancer; 2017 Feb; 104():111-118. PubMed ID: 28212992
[TBL] [Abstract][Full Text] [Related]
16. A fatal case of alemtuzumab-associated interstitial pneumonitis.
Creelan B; Ferber A
Am J Ther; 2008; 15(1):82-4. PubMed ID: 18223357
[TBL] [Abstract][Full Text] [Related]
17. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.
Kikuchi S; Umezawa Y; Hayashi M; Yanaba K; Fukuchi O; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2016 Jun; 43(6):712-3. PubMed ID: 26703791
[No Abstract] [Full Text] [Related]
18. Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.
Sakata S; Matsuoka Y; Kawahara K; Kakiuchi Y; Takaki A; Hirosue A; Yoshida R; Saeki S; Fujii K; Nakayama H
Respir Investig; 2018 Mar; 56(2):195-198. PubMed ID: 29548660
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study.
Imafuku S; Honma M; Okubo Y; Komine M; Ohtsuki M; Morita A; Seko N; Kawashima N; Ito S; Shima T; Nakagawa H
J Dermatol; 2016 Sep; 43(9):1011-7. PubMed ID: 26919410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
